by CBDA Membership | March 12, 2020 | Legislative Policy Updates John Venardos
Executive Summary // On March 5, FDA issued a 15-page report to Congress concerning CBD. Below, the CBD Association explores five issues raised by that report and invites feedback. Those issues are: 1. Can FDA and the Administration define an acceptable regulatory...
by CBDA Membership | March 9, 2020 | Legislative Policy Updates John Venardos
At the CBD Association, we hear from two broad classes of stakeholders interested in legislative developments involving cannabinoids, especially CBD. The first are businesses which today have ‘skin in the game’. These include growers, processors, contract...
Recent Comments